Terumo Corporation (TRUMF) 23.8700 $TRUMF
Research and Markets: Global Market Study on Disposable Plastic Blood Bags 2014-2020: Terumo Corporation Dominates the $4 Billion Industry
Business Wire - Wed Jul 08, 9:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pr7s8j/global_market) has announced the addition of the "Global Market Study on Disposable Plastic Blood Bags: Single Blood Bags to Witness Highest Growth by 2020" report to their offering.
Global Market Study on Disposable Plastic Blood Bags 2014-2020: Terumo Corporation Dominates the $4 Billion Industry
M2 - Wed Jul 08, 8:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8twvgf/global_market) has announced the addition of the "Global Market Study on Disposable Plastic Blood Bags: Single Blood Bags to Witness Highest Growth by 2020" report to their offering. The global disposable plastic blood bags market is estimated at USD 2,44,286.8 thousand in 2014. It is likely to grow with a CAGR of 9.1% and reach USD 4,13,084.8 thousand in 2020. Globally, the disposable plastic blood bags market is witnessing significant growth due to increasing prevalence of blood related disorders and advancement in the technology. In addition, growing aging population and rising government initiatives in the field are driving the disposable plastic blood bags market. However, factors such as risk associated with the blood transfusion and lack of awareness are restraining the global market for disposable plastic blood bags. In addition, poor healthcare infrastructure negatively impacts the growth of the global disposable plastic blood bags market. North America has the largest market for the global disposable plastic blood bags market. Single blood bags are the largest segment in the overall disposable plastic blood bags market. In end users market, hospitals are the largest segment. In terms of growth, Asia is the fastest growing region, single blood bags are the fastest growing type of bags and blood banks are the fastest growing type of end users. North America market for disposable plastic blood bags is estimated at USD 83,670.7 thousand in 2014 and is expected to reach USD 1,42,983.2 thousand in 2020, growing at a CAGR of 9.3%. Some of the latest trends that have been observed in the global disposable plastic blood bags market are the growing number of mergers and acquisitions by companies and increasing use of RFID technology for easy identification of blood bags. Terumo Corporation is a leading player in the global disposable plastic blood bags market, with a share of about 38.7% in 2013. Some of the other major players in disposable plastic blood bags market are Fresenius SE & Co. KGaA, Grifols, S.A., MacoPharma SA, Haemonetics Corporation and others. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry Overview Chapter 6 Market Size and Forecast by Type Chapter 7 Market Size and Forecast by End Users Chapter 8 Market Size and Forecast by Geography Chapter 9 Competitive Scenario Chapter 10 Company Profiles - AdvaCare Pharma - Fresenius SE & Co. KGaA - GenesisBPS - Grifols, S.A. - Haemonetics Corporation - JMS Co., Ltd. - Kawasumi Laboratories, Inc. - MacoPharma, S.A. - Neomedic Limited - SURU International Pvt. Ltd. - Shandong Weigao Group Medical Polymer Co., Ltd. - Shanghai Transfusion Technology Co., Ltd. - Sichuan Nigale Biomedical Co., Ltd. - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/8t...bal_market
HAE: 39.22 (+0.51)
OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation
PR Newswire Europe - Wed Jul 01, 9:30AM CDT
HONG KONG and FT LAUDERDALE, Florida, July 1, 2015 /PRNewswire/ --
Disposable Syringes Market (Safety and Conventional Syringes): Global Industry Analysis 2014 - 2022
M2 - Wed Jul 01, 9:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jlbkkq/disposable) has announced the addition of the "Disposable Syringes Market (safety and conventional syringes): Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022" report to their offering. The global disposable syringes market was valued at USD 4,935.7 million in 2013 and is projected to reach USD 7,552.5 million by 2022, expanding at a CAGR of 4.9% during the forecast period from 2014 to 2022. Growth in the injectable drugs market along with increasing needlestick injuries has boosted demand for safe disposable syringes across the world. Disposable syringes have been identified as one of the fastest growing segments of the syringe market, accounting for approximately 70% to 80% of the global market in 2013. Globally, disposable syringes are becoming more popular than re-usable syringes, primarily due to cost, accuracy, sterility, and ease of handling. Increasing cases of needlestick injuries, strict regulatory guidelines, and overall growth in the injectable drugs market have been identified as the major factors driving the growth of the global disposable syringes market. The disposable syringes market has been segmented into two major types: safety syringes and conventional syringes. Syringes equipped with safety mechanisms are known as safety syringes. Safety syringes have been further categorized into automatic retractable safety syringes, manual retractable safety syringes, and non-retractable safety syringes. Conventional syringes are not equipped with any kind of safety mechanisms. Conventional syringes have been classified into syringes without needles and syringes attached with needles. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Disposable Syringes Market Overview Chapter 4 Global Disposable Syringes Market Revenue (USD Million) and Volume (Million Units), by Type, 2012 - 2022 Chapter 5 Global Disposable Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2012 - 2022 Chapter 6 Recommendations Chapter 7 Company Profiles - B. Braun Melsungen AG - Becton, Dickinson & Company - CODAN Medizinische Ger?te GmbH & Co KG - Covidien plc (Medtronic plc) - Gerresheimer AG - Retractable Technologies, Inc. - Smiths Medical - Star Syringe Ltd. - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/jlbkkq/disposable
BDX: 144.27 (+2.44), UNIS: 1.94 (+0.06), MDT: 74.37 (+1.28), RVP: 3.86 (+0.02)
Prefilled Syringes Market Report: Base Year is 2014 with Forecasts for 2015 to 2025
M2 - Wed Jul 01, 8:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mg74nr/prefilled) has announced the addition of the "Prefilled Syringes Market (3rd Edition), 2015 - 2025" report to their offering. Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern devices have become preferred devices for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. The rising demand has also driven the manufacturers to introduce improvements in technology related to the material of prefilled syringes and lubrication (to reduce leachables and extractables). These developments will aid an increasing number of biologic drugs to reach the market. Additionally, the companies have developed multi-chamber prefilled syringes for use with lyophilised drugs. In our research, we have looked at how these developments and other factors are shaping the market and discussed the factors creating opportunities for various stakeholders in the market. The Prefilled Syringes Market (3rd Edition)' report provides a comprehensive analysis of the state of prefilled syringes market. Starting with the basic introduction to prefilled syringes, their origin, components and manufacturing material, this report talks about needlestick injuries and looks at the safety laws and legislations across major regional markets for prefilled syringes. A key objective of the report is to enumerate various prefilled syringe systems available in the market, drugs available in these syringes and the corresponding market potential across different geographical regions. We have discussed various historical/likely future trends which have shaped/will shape the US, European, Japanese, Chinese, Indian and rest of the world markets. We have also included a detailed overview of biologics and biosimilars, one of the primary growth drivers of this market. The study focuses on analysing the existing market size and potential future growth of these drug delivery devices across different drug therapeutic classes and regions. The forecast, over the next ten years, has been presented both in terms of volume (number of units) and value (USD billion). It takes into account the likely price variation which will occur as a result of mass adoption and increased competition. Owing to uncertainty surrounding the adoption of prefilled syringes in newer drug classes (which are currently in pipeline); we have also done a multi-variate sensitivity analysis to understand the various market growth scenarios. The market forecasts across different segments and regions have been presented till 2025. 2014 is the base year; actual figures have been sourced and analysed from publicly available information. Unless otherwise specified, all figures are presented in USD. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction To Prefilled Syringes 4. Needlestick Injuries 5. Growth Drivers 6. Products Available in Prefilled Syringes 7. Recent Developments and Applications of Prefilled Syringes 8. Manufacturers of Prefilled Syringe 9. PFS Component Manufacturers 10. Global Pen and Auto-Injector Manufacturers 11. SWOT Analysis 12. Leading Regional Markets for Prefilled Syringe Systems, 2015 - 2025 13. Global Prefilled Syringes Market Forecast, 2015 - 2025 14. Interview Transcripts 15. Conclusion 16. Appendix 1: Tabulated Data 17. Appendix 2: List of Companies and Organisations Companies Mentioned - ARTE CORPORATION - AbbVie/Eisai - Aguettant - Amgen - Aptar Stelmi - Becton Dickinson (BD) - Bespak - DALI Medical DevicesElcam Medical - Daikyo Crystal Zenith - Datwyler - Elcam Medical - EZ-fill Syringes - Future Injection Technologies - Gerresheimer - J.O. Pharma Co., Ltd. - Nipro Corporation - Nuova Ompi - Owen Mumford - Pfizer - Plajex: Plastic PFS - Roselabs Group - SCHOTT - Takeda - Taisei Kako Co., Ltd. - Terumo Corporation - Teva Pharmaceuticals - TopPac - Unilife Corporation - VF-Syringe Glass PFS - Vetter Pharma - WeGo: Glass PFS - West Pharmaceutical Services, Inc. - YangZhong Wealth Metal Co., Ltd. - Youlyy Industrial Co., Ltd. - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/mg74nr/prefilled
WST: 59.92 (+0.16), UNIS: 1.94 (+0.06), AMGN: 154.10 (+2.79)
Peripheral Vascular Stents Pipeline Review, 2015
M2 - Fri Jun 26, 4:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wtlrn6/peripheral) has announced the addition of the "Peripheral Vascular Stents - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key peripheral vascular stents pipeline products. Scope - Extensive coverage of the Peripheral Vascular Stents products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Peripheral Vascular Stents - Pipeline Products under Development by Companies 5 Peripheral Vascular Stents Companies and Product Overview 6 Peripheral Vascular Stents- Recent Developments 7 Appendix Companies Featured: - 3D Biotek, LLC - 480 Biomedical, Inc. - Abbott Vascular Inc. - Andramed GmbH - Biotronik SE & Co. KG - Boston Scientific Corporation - Contego Medical, LLC - Cook Medical Incorporated - Cordis Corporation - CorInnova, Inc. - Cytograft Tissue Engineering, Inc. - Elixir Medical Corporation - HEXACATH - InspireMD, Inc. - Lifetech Scientific (Shenzhen) Co., Ltd. - MicroVention, Inc. - Nipro Corporation - NSVascular, Inc. - Palmaz Scientific, Inc. - Stentys, SA - Stron Medical - Taewoong Medical Co.,Ltd. - Tepha, Inc. - Terumo Corporation - University of Texas Medical Branch at Galveston - Veniti, Inc. - Veryan Medical Limited - VueKlar Cardiovascular Ltd. - W. L. Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/wtlrn6/peripheral
BSX: 17.60 (+0.15), NSPR: 0.25 (+0.01)
Global Interventional Cardiology & Peripheral Vascular Devices Market 2015 - Forecasts to 2019
M2 - Wed Jun 10, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6kzjg4/interventional) has announced the addition of the "Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019" report to their offering. The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4% The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. The angioplasty stents segment accounted for the largest share of the interventional cardiology and peripheral vascular devices market during the forecast period. The large share of this segment is attributed to the rising prevalence of cardiovascular diseases and increasing initiatives by companies for developing new and technologically advanced stents for better clinical outcomes. Major factors contributing to the growth of the interventional cardiology and peripheral vascular devices market include rising aging population, increasing demand of minimally invasive procedures, rising incidence of cardiovascular diseases, and technological advancements. According to the World Health Organization, in 2012, 17.5 million people died due to CVDs; this figure accounted for 31% of the global deaths in 2012. Furthermore, in the same year, 16 million people aged below 70 years died due to non-communicable diseases; of this, 37% deaths were related to CVDs. Emerging markets in Asia have opened an array of opportunities for the growth of the interventional cardiology and peripheral vascular devices market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market. Key players in this market include Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic Inc. (U.S.), Terumo Corporation (Japan), and Volcano Corporation (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Angioplasty Market Size, By Type of Procedure 8 Angioplasty Balloons Market, By Type 9 Angioplasty Stents Market, By Type 10 Catheters Market, By Type 11 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type 12 Inferior Vena Cava (IVC) Filters Market, By Type 13 Plaque Modification Devices Market, By Type 14 Hemodynamic Flow Alteration Devices Market, By Type 15 Accessories Market, By Type 16 Interventional Cardiology and Peripheral Vascular Devices Market, By Region 17 Competitive Landscape 18 Company Profiles - Abbott Laboratories - B. Braun Melsungen AG - Boston Scientific Corporation - C.R. Bard - Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) - Medtronic, Inc. - Spectranetics International BV - St. Jude Medical, Inc. - Terumo Corporation - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/6k...rventional
BSX: 17.60 (+0.15), SPNC: 24.87 (+0.36), JNJ: 99.53 (+1.13), ABT: 49.93 (+0.74), BCR: 174.54 (+3.34), MDT: 74.37 (+1.28), VOLC: 17.99 (+0.01), STJ: 75.33 (+0.79)
Blood Processing Supplies and Equipment Market 2015 - Global Strategic Business Report
M2 - Tue Jun 02, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mk83rc/blood_processing) has announced the addition of the "Blood Processing Supplies and Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Blood Processing Supplies and Equipment in US$ Thousands by the following Product Group/Segments: - Blood Processing Devices (Blood Bank Freezers, Blood Bank Refrigerators, Blood Cell Processors, Blood Grouping Analyzers, & Hematocrit Centrifuges) - Blood Processing Consumables & Supplies (Blood Administration Sets, Blood Collection Needles, Blood Collection Tubes & Micro Collectors, Blood Collection Tube Adapters, Blood Donor Sets, Blood Sample Mailers, Blood Sampling Kits, Blood Lancets, Blood Tube Mixes, Donor Blood (Blood Bank) Mix, Blood Cell Washer Bags, Blood Filters, Blood Grouping Reagents, Coagulation Reagents, Hematology Reagents, Hematology Stains, Control Plasmas, Microscopic Slides, Sedimentation Tubes, Slide Stainers, Specimen Labels, Test Tube Racks, Vials, Cleaning Solutions, & Blood Warming Coils/Pouches). The report profiles 98 companies including many key and niche players such as - Beckman Coulter, Inc. - Becton, Dickinson and Company - Fresenius Kabi AG - Fenwal, Inc. - Haemonetics Corporation - Immucor, Inc. - MacoPharma SA - Stago - Terumo Corporation - Terumo BCT, Inc. Key Topics Covered: 1. INDUSTRY OVERVIEW 2. COMPETITIVE LANDSCAPE 3. MARKET DYNAMICS 4. BLOOD COMPONENTS & DERIVATIVES 5. BLOOD BANKING 6. AUTOLOGOUS BLOOD TRANSFUSIONS VIS-A-VIS ALLOGENIC BLOOD TRANSFUSIONS 7. AUTOLOGOUS TRANSFUSIONS: MINIMIZING RISK OF BLOOD-BORNE DISEASES 8. BLOOD PROCESSING SUPPLIES AND EQUIPMENT: AN OVERVIEW 9. BLOOD TESTING DEVELOPMENTS - A HISTORIC REVIEW 10. PRODUCT INNOVATIONS/INTRODUCTIONS 11. RECENT INDUSTRY ACTIVITY 12. FOCUS ON SELECT PLAYERS 13. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 98 (including Divisions/Subsidiaries 110) - The United States (52) - Canada (3) - Japan (9) - Europe (31) - - France (2) - - Germany (7) - - The United Kingdom (6) - - Italy (5) - - Spain (2) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (13) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/mk...processing
HAE: 39.22 (+0.51)
MicroVention to Locate Its New 205,000 Square-Foot Worldwide Headquarters At Summit Office Campus in Aliso Viejo
PR Newswire - Mon Jun 01, 9:00AM CDT
MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation and a global neurovascular company, announced today that it will build its new 205,000 square-foot worldwide headquarters at the Summit Office Campus in Aliso Viejo, CA, the city where the Company was originally founded.
Investing in Global Medical Device Sector: Risk Analysis and Management 2014-2020
M2 - Fri May 22, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tlb9zv/investing_in) has announced the addition of the "Investing in Global Medical Device Sector: Risk Analysis and Management 2014-2020" report to their offering. The global medical devices (MD) market represents a steady growing industrial sector as well as an attractive investment opportunity for profitable rewards. However, the potential for greater investment return may be constrained by a number of barriers and risks in global medical device market - most notably, maturing industry growth stage, challenging and changing regulatory laws and procedures, and declining profit margins. Hence, in-depth information and enhanced strategic intelligence are needed to minimize the potential risks associated with new entrants into the global medical device industry. This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (arising from the surrounding environments) in global medical devices industry and market. The major internal risks recognized in this industry include industry growth stage, industry competition pressure, market entry barriers, industry volatility, and technology challenge. The major external risks include factors like profit decline, regulation force, effect of foreign direct investment, and other risks (namely shortage of upstream supply, competition from substitutes, and purchase potential decrease). The risk evaluation and threat rating concentrate on worldwide medical device market under the industry conditions and environments in 2014. Forecasts and projections have been performed for the trend of industry risk over the next six years (2014-2020). All the identified risk factors are measured quantitatively according to our novel numeric system, i.e. each risk is evaluated with our Risk Index Number (RIN) and Risk Intensity Level (RIL). These in-depth appraisals and analysis about risk considerations & controls provide a comprehensive understanding of the current risk factors and likelihood of risk development trends. Moreover, this report also provides wise risk management strategies and concludes Critical Success Factors (CSFs) to help identify fresh growth point and overcome the threats and obstacles of doing manufacture/business in global medical device industry. Key Topics Covered: 1. Introduction 2. Internal Risk 3. External Risk 4. Summary and Forcast 5. Critical Success Factors (CSFS) Companies Mentioned - 3M Co. - Abbott Laboratories - Allergan Inc. - Baxter International Inc. - Becton, Dickinson and Co. - Boston Scientific Corp. - Cardinal Health Inc. - Covidien plc - Essilor International SA - Fresenius Medical Care AG & Co. KGAA - GE Healthcare - Johnson & Johnson - Koninklijke Philips NV - Medtronic Inc. - Novartis AG - Siemens AG - St. Jude Medical Inc. - Stryker Corp. - Terumo Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/tl...vesting_in
ZMH: 113.56 (+0.29), MMM: 154.95 (+1.20), ABT: 49.93 (+0.74), MDT: 74.37 (+1.28), CAH: 85.48 (+1.32), AGN: 312.13 (+8.03), BSX: 17.60 (+0.15), JNJ: 99.53 (+1.13), BAX: 37.61 (+0.59), STJ: 75.33 (+0.79), SYK: 96.37 (+0.71), NVS: 103.22 (+3.20)
Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecasts for the $289 Billion Market
M2 - Fri May 22, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xgr8bv/global_medical) has announced the addition of the "Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecast" report to their offering. The global medical devices (MD) market will see a steady growth over the coming years with the sales revenue and international trade value reaching $543.9 bn and $289.2 bn respectively by 2020 driven by aging population, increasing healthcare expenditure and technology advancement. Global Medical Devices Market 2012-2020 examines the worldwide market of medical devices through a comprehensive review of information sources. This report provides historical performance, in-depth analysis and trend forecast of market size and share, sales revenue, international trade, R&D investment, geographic distributions and product categories by device area in the global medical device market and industry. Historical statistics cover the past three years and forecast data characterize the 2014-2020 period. Market analyses and discussions of commercial drivers, restraints and challenges, emerging market opportunities, competitive environment and technological developments are also reviewed in the report. Geographic sub-markets include continents such as North America, Europe, Asia Pacific region, Latin America and the rest of world, with 12 country-based markets analyzed in detail for market overview, industry landscape, healthcare system and/or regulation issues. Per capita MD expenditure/availability in major economic markets (on country basis) is compared and analyzed. Medical devices are segmented by device area such as Diagnostic Imaging Devices, In Vitro Diagnostics, Cardiology, Orthopedics, Ophthalmics, General and Plastic Surgery, Endoscopy, Dental, Diabetic Care, Wound Management, Nephrology, General Hospital and Healthcare, Ear, Nose and Throat, Neurology and others. The market data and forecast trends are provided for each sub-market in the time range of 2012-2020, highlighted by 62 tables and figures totally. The top 40 medical device manufacturers in 2014 are listed and 20 of them are profiled and studied. Key Topics Covered: 1 Introduction 2 Market Analysis: Drivers, Restraints, Challenge and Opportunity 3 Geographic Distribution of Global Medical Device Market 4 Market Trends of Global Medical Devices by Device Area 5 International Trade of Medical Devices 6 Major Medical Device Manufacturers Companies Mentioned - 3M Co. - Abbott Laboratories - Allergan Inc. - Baxter International Inc. - Becton, Dickinson and Co. - Boston Scientific Corp. - Cardinal Health Inc. - Covidien plc - Essilor International SA - Fresenius Medical Care AG & Co. KGAA - GE Healthcare - Johnson & Johnson - Koninklijke Philips NV - Medtronic Inc. - Novartis AG - Siemens AG - St. Jude Medical Inc. - Stryker Corp. - Terumo Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/xg...al_medical
ZMH: 113.56 (+0.29), MMM: 154.95 (+1.20), ABT: 49.93 (+0.74), MDT: 74.37 (+1.28), CAH: 85.48 (+1.32), AGN: 312.13 (+8.03), BSX: 17.60 (+0.15), JNJ: 99.53 (+1.13), BAX: 37.61 (+0.59), STJ: 75.33 (+0.79), SYK: 96.37 (+0.71), NVS: 103.22 (+3.20)
Olympus to Distribute Terumo GLIDEWIRE®, Urologic Hydrophilic Coated Guidewire for U.S. Urology Market
PR Newswire - Fri May 15, 2:31PM CDT
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE® Urologic Hydrophilic Coated Guidewire, a device cleared by the FDA for urological use. Beginning immediately, the Olympus Urology and Stone Management sales force will distribute the device to U.S. customers.
Cannulas Market by Product, Material & End Users - Global Forecast to 2020
M2 - Wed May 06, 9:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/84mqf9/cannulas_market) has announced the addition of the "Cannulas Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, Cardioplegia, Suction, Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & End Users (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2020" report to their offering. The global cannulas market is expected to grow at a CAGR of 5.6% from 2015 to 2020 to reach $135.5 million by 2020 from $97.6 million in 2014.The market is expected to grow in the forecast period owing to increased investment in R&D, growing demand of minimally invasive surgery (MIS) procedures, large pool of patients, and increasing number of surgeries. However uncertain regulatory framework is hindering the growth of cannula market. On the basis of products, the market is divided into the global cannulas market is segmented into cardiac cannulas, vascular cannulas, nasal cannulas, arthroscopy cannulas, dermatology cannulas and others (floating spinal cannulas, vitreoretinal cannulas, hysterosalpingography cannulas). On the basis of end users, the market is divided into hospitals, ambulatory surgical centers, and others (blood banks and home healthcare facilities). Hospitals segment accounted the largest share of the cannula market as compared to ambulatory surgical centers, and others. On the basis of material, the market is divided into plastic, silicone, and metal. Silicone is expected to be the fastest-growing segment, owing to the increasing usage of silicone-based cannulas in oxygen therapies to provide continuous oxygen supply to the elderly population and patients suffering from respiratory disorders. Geographically, the cannulas market is dominated by North America, followed by Europe. However, the Asia-Pacific region is expected to be the fastest growing region in cannula market during the forecast period. Increasing awareness about MIS techniques in countries such as China, India, and Japan, increasing purchasing power of the middle class population are augmenting the growth of this market in Asia-Pacific region. The key players in cannulas market include Medtronic plc (U.S.), Edward Lifesciences Corp. (U.S.), Terumo Corporation (Japan), Sorin Group (Italy), and Maquet Holding B.V. & Co. KG (Germany). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Cannulas Market, By Application 8 Cannula Market, By Product 9 Global Cannulas Market, By Material 10 Global Cannulas Market, By End User 11 Cannulas Market, By Region 12 Competitive Landscape 13 Company Profiles - Boston Scientific Corporation - Conmed Corporation - Edward Lifescience Corporation - Maquet Holding B.V. & Co. KG. - Medtronic PLC. - Smith & Nephew PLC. - Smiths Medical - Sorin Group - Teleflex Incorporated - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/84...las_market
BSX: 17.60 (+0.15), SNN: 34.89 (+0.83), MDT: 74.37 (+1.28), TFX: 135.95 (+1.47)
Medical Oxygen Systems - 2015 Global Strategic Business Report
M2 - Fri Apr 17, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3p22jk/medical_oxygen) has announced the addition of the "Medical Oxygen Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Medical Oxygen Systems in US$ Thousands by the following Segments: Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 66 companies including many key and niche players such as: - Chart Industries, Inc. (US) - AirSep Corporation (US) - Chart SeQual Technologies, Inc. (US) - DeVilbiss Healthcare (US) - Inogen (US) - Inovo, Inc. (US) - Invacare Corporation (US) - Medical Gas Solutions (UK) - Philips Healthcare (US) - Terumo Corporation (Japan) - Weinmann Ger?te f?r Medizin GmbH Co. KG (Germany) Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET GROWTH DRIVERS, TRENDS AND ISSUES 3. HOME OXYGEN THERAPY MARKET - A CLOSER LOOK 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/INNOVATIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 66 (including Divisions/Subsidiaries - 82) The United States (46) Canada (3) Japan (4) Europe (22) - France (3) - Germany (7) - The United Kingdom (
- Rest of Europe (4) Asia-Pacific (Excluding Japan) (6) Africa (1) For more information visit http://www.researchandmarkets.com/research/3p...cal_oxygen
IVC: 20.62 (+0.25), GTLS: 33.57 (-1.41)
Body Temperature Monitoring Devices - Global Strategic Business Report 2015-2020: Its Time for Smart, No-Fuss Thermometers
M2 - Wed Apr 01, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dcjdnj/body_temperature) has announced the addition of the "Body Temperature Monitoring Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Body Temperature Monitoring Devices in US$ Thousands by the following Product Segments: - Digital Thermometers - Infrared Thermometers - Electronic Temperature Monitors - Temperature Strips The report profiles 65 companies including many key and niche players such as: - 3M Company (US) - A&D Medical/LifeSource (US) - Actherm, Inc. (Taiwan) - American Diagnostic Corporation (US) - Briggs Healthcare (US) - Exergen Corporation (US) - Geratherm Medical AG (Germany) - Hicks Thermometers (India) Limited (India) - Kaz USA, Inc. (US) - LCR Hallcrest LLC (US) - Medtronic PLC (US) - Microlife Corporation (Taiwan) - Omron Healthcare, Inc. (Japan) - Mediaid, Inc. (US) - RG Medical Diagnostics (US) - Sanomedics International Holdings, Inc. (US) - Terumo Corporation (Japan) - Welch Allyn, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS & ISSUES 3. AN INTRODUCTION TO THERMOMETERS 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/INNOVATIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 65 (including Divisions/Subsidiaries (73) - The United States (27) - Canada (1) - Japan (5) - Europe (21) - Germany (5) - The United Kingdom ( - Italy (3) - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (17) - Latin America (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/dc...emperature
MMM: 154.95 (+1.20), MDT: 74.37 (+1.28)
MediPoint: Coronary Stents - South America Analysis and Market Forecasts to 2020
M2 - Wed Mar 25, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lz276h/medipoint) has announced the addition of the "MediPoint: Coronary Stents - SA Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Minimally-invasive techniques such as stenting have been widely adopted in Brazil. The coronary stents market will be driven by the rising prevalence of CAD, the growing aging population, and the potential cost savings associated with DES technologies. Scope - An overview of Coronary Stents, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the SA Coronary Stents market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Coronary Stents. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Coronary Stents sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Boston Scientific Corporation - Medtronic - Alvimedica - Amaranth Medical - amg International - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Cardionovum - C.R. Bard - Elixir Medical Corporation - eucatech AG - Hexacath - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MicroPort Scientific Corporation - Minvasys - MIV Therapeutics - Opto Circuits - OrbusNeich Medical - Relisys Medical Devices - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/lz276h/medipoint
BSX: 17.60 (+0.15), MDT: 74.37 (+1.28)
Leading 100 Global Medical Devices Companies 2015
M2 - Mon Mar 23, 10:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nnxw77/global_medical) has announced the addition of the "Global Medical Devices 100 - An Industry Report" report to their offering. The global medical devices industry will witness significant opportunities for growth in the coming decade. It is predicted that the global medical devices market will reach $398.0bn in 2017 This newly launched report covers various aspects of the global medical devices sector including news, as well as financial/non-financial information and stock market analysis of leading 100 global medical devices companies. There has been an increase in demand for the refurbished medical devices market globally, along with the new equipments market. Until a decade ago, refurbished medical devices were exported to developing countries, and the suppliers involved were not professionally trained, which restrained the growth of this market. However, economic crises and cost containment issues related to healthcare budgets in developed countries like the U.S. and the recent economic recession of Europe has triggered the growth of this market in these countries. Additionally, there has been a surge of trained professionals in this segment. Report Highlights: - Leading 100 medical devices companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical devices companies - International presence of global medical devices companies - R&D activities by global medical devices companies Key Topics Covered: 1: Rankings of Medical Devices Companies Globally 1.1: Leading 100 Medical Devices Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Devices Companies Globally 1.3: Most Profitable 25 Medical Devices Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Devices Companies Globally 3: Key News of Medical Devices Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Devices Companies Globally 5: International Presence of Global Medical Devices Companies 6: Research and Development Activities by Global Medical Devices Companies 7: Mergers and Acquisitions among Global Medical Devices Companies Companies Mentioned (Partial List) - Amplifon SpA (Italy) - Bastide le Confort Medical (France) - Digital Optics Co Ltd (South Korea) - Edan Instruments Incorporated (China) - Fujifilm Holdings Corporation (Japan) - Guangzhou Improve Medical Instruments Company Limited (China) - Hitachi High Technologies Corp (Japan) - JVM Co Ltd (South Korea) - Mindray Medical International Limited - adr - ADR (China) - Nan Liu Enterprise Co. Ltd. (Taiwan) - Owens & Minor, Incorporated (United States) - Patterson Companies, Inc. (United States) - Pw Medtech Group Ltd (China) - Suzuken Co (Japan) - Sysmex Corporation (Japan) - Techcomp (Holdings) Ltd. (Singapore) - Teleflex Incorporated (United States) - Terumo Corporation (Japan) - Waters Corporation (United States) - Yamashita Medical Instruments Company Limited (Japan) For more information visit http://www.researchandmarkets.com/research/nn...al_medical
TFX: 135.95 (+1.47), MR: 26.11 (+0.38), WAT: 128.53 (+3.12), OMI: 33.76 (+0.58)
South Africa Cardiovascular Devices Market Opportunity and Growth Trend Forecasts to 2020
M2 - Thu Mar 19, 6:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2nnrg/south_africa) has announced the addition of the "South Africa Cardiovascular Devices Market Opportunity and Growth Trend Forecast Till 2020" report to their offering. The Market Intelligence report provides critical market data for South Africa cardiovascular devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as cardiac assist devices, cardiac catheters and guidewires, cardiac rhythm management, cardiovascular heart valve and repair, cardiovascular monitoring systems, cardiovascular surgery, interventional cardiovascular devices, and peripheral vascular devices. Key Topics Covered: 1 Tables & Charts 2 Introduction 3 Scope of the Report 4 South Africa Market for Cardiovascular Devices (2007-2020) 5 South Africa Market for Cardiac Assist Devices (2007-2020) 6 South Africa Market for Cardiac Catheters and Guidewires (2007-2020) 7 South Africa Market for Cardiac Rhythm Management (2007-2020) 8 South Africa Market for Cardiovascular Heart Valve and Repair (2007-2020) 9 South Africa Market for Cardiovascular Monitoring Systems (2007-2020) 10 South Africa Market for Cardiovascular Surgery (2007-2020) 11 South Africa Market for Interventional Cardiovascular Devices (2007-2020) 12 South Africa Market for Peripheral Vascular Devices (2007-2020) 13 Recent Events and Developments 14 Appendix Companies Mentioned - Abbott Laboratories - AtriCure, Inc. - Biosense Webster, Inc. - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - C.R. Bard, Inc. - Cardiac Science Corporation - Cordis Corporation - Datascope Corp. - Edwards Lifesciences Corporation - ev3 Inc. - Fukuda Denshi Co., Ltd. - GE Healthcare - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Sorin Group - St. Jude Medical Inc. - Terumo Corporation - Thoratec Corporation - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/v2...uth_africa
ABT: 49.93 (+0.74), BCR: 174.54 (+3.34), MDT: 74.37 (+1.28), EW: 147.16 (+2.09), OSIS: 71.42 (+1.63), ATRC: 24.31 (+0.89), BSX: 17.60 (+0.15), STJ: 75.33 (+0.79), THOR: 45.20 (+0.61)
United States Patient Monitoring and Diagnostic Systems Market Assessment and Forecast To 2020
M2 - Wed Mar 18, 7:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zvr9s7/us_patient) has announced the addition of the "US Patient Monitoring and Diagnostic Systems Market Assessment and Forecast To 2020" report to their offering. The Market Intelligence report provides critical market data for US patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as blood pressure monitors, cardiovascular monitoring systems, blood glucose monitoring devices, hearing diagnostics, micro-electromechanical systems multiparameter patient monitors, remote monitoring systems, sleep apnea diagnostic systems and wireless hospital ambulatory monitors. Patient Monitoring and Diagnostics Market Segmentation - Blood Pressure Monitors - Mercury BP Monitors - Aneroid BP Monitors - Automatic BP Monitors - Cardiovascular Monitoring Systems - ECG Monitoring Equipment - ECG Stress Testing Systems - Holter Monitoring Systems - Event Monitoring Systems - Blood Glucose Monitoring Devices - Blood Glucose Meters - Blood Glucose Test Strips - Continuous Glucose Monitoring Systems - Hearing Diagnostics - Audiometer - Otoscope - Micro-Electromechanical Systems - Multiparameter Patient Monitors - Critical Care Monitors - Perioperative Care Monitors - Remote Monitoring Systems - Sleep Apnea Diagnostic Systems - Fixed Polysomnography Systems - Portable Polysomnography Systems - Wireless Hospital Ambulatory Monitors Key Topics Covered: 1 Tables & Charts 2 Introduction 3 Scope of the Report 4 US Market for Patient Monitoring and Diagnostics (2007-2020) 5 US Market for Blood Pressure Monitors (2007-2020) 6 US Market for Cardiovascular Monitoring Systems (2007-2020) 7 US Market for Blood Glucose Monitoring Devices (2007-2020) 8 US Market for Hearing Diagnostics (2007-2020) 9 US Market for Micro-Electromechanical Systems(2007-2020) 10 US Market for Multiparameter Patient Monitors (2007-2020) 11 US Market for Remote Monitoring Systems (2007-2020) 12 US Market for Sleep Apnea Diagnostic Systems (2007-2020) 13 US Market for Wireless Hospital Ambulatory Monitors (2007-2020) 14 Recent Events and Developments 15 Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Astro-Med, Inc. - Bayer HealthCare AG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial Co., Ltd. - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Corporation - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/zvr9s7/us_patient
ABT: 49.93 (+0.74), MDT: 74.37 (+1.28), CAH: 85.48 (+1.32), COV: 106.71 (-1.36), EW: 147.16 (+2.09), OSIS: 71.42 (+1.63), MR: 26.11 (+0.38), BSX: 17.60 (+0.15), CMD: 95.40 (unch), BABY: 42.30 (+1.11), ALOT: 14.23 (+0.03), STJ: 75.33 (+0.79)
Research and Markets: Global Market Study on Disposable Plastic Blood Bags 2014-2020: Terumo Corporation Dominates the $4 Billion Industry
Business Wire - Wed Jul 08, 9:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pr7s8j/global_market) has announced the addition of the "Global Market Study on Disposable Plastic Blood Bags: Single Blood Bags to Witness Highest Growth by 2020" report to their offering.
Global Market Study on Disposable Plastic Blood Bags 2014-2020: Terumo Corporation Dominates the $4 Billion Industry
M2 - Wed Jul 08, 8:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8twvgf/global_market) has announced the addition of the "Global Market Study on Disposable Plastic Blood Bags: Single Blood Bags to Witness Highest Growth by 2020" report to their offering. The global disposable plastic blood bags market is estimated at USD 2,44,286.8 thousand in 2014. It is likely to grow with a CAGR of 9.1% and reach USD 4,13,084.8 thousand in 2020. Globally, the disposable plastic blood bags market is witnessing significant growth due to increasing prevalence of blood related disorders and advancement in the technology. In addition, growing aging population and rising government initiatives in the field are driving the disposable plastic blood bags market. However, factors such as risk associated with the blood transfusion and lack of awareness are restraining the global market for disposable plastic blood bags. In addition, poor healthcare infrastructure negatively impacts the growth of the global disposable plastic blood bags market. North America has the largest market for the global disposable plastic blood bags market. Single blood bags are the largest segment in the overall disposable plastic blood bags market. In end users market, hospitals are the largest segment. In terms of growth, Asia is the fastest growing region, single blood bags are the fastest growing type of bags and blood banks are the fastest growing type of end users. North America market for disposable plastic blood bags is estimated at USD 83,670.7 thousand in 2014 and is expected to reach USD 1,42,983.2 thousand in 2020, growing at a CAGR of 9.3%. Some of the latest trends that have been observed in the global disposable plastic blood bags market are the growing number of mergers and acquisitions by companies and increasing use of RFID technology for easy identification of blood bags. Terumo Corporation is a leading player in the global disposable plastic blood bags market, with a share of about 38.7% in 2013. Some of the other major players in disposable plastic blood bags market are Fresenius SE & Co. KGaA, Grifols, S.A., MacoPharma SA, Haemonetics Corporation and others. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry Overview Chapter 6 Market Size and Forecast by Type Chapter 7 Market Size and Forecast by End Users Chapter 8 Market Size and Forecast by Geography Chapter 9 Competitive Scenario Chapter 10 Company Profiles - AdvaCare Pharma - Fresenius SE & Co. KGaA - GenesisBPS - Grifols, S.A. - Haemonetics Corporation - JMS Co., Ltd. - Kawasumi Laboratories, Inc. - MacoPharma, S.A. - Neomedic Limited - SURU International Pvt. Ltd. - Shandong Weigao Group Medical Polymer Co., Ltd. - Shanghai Transfusion Technology Co., Ltd. - Sichuan Nigale Biomedical Co., Ltd. - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/8t...bal_market
HAE: 39.22 (+0.51)
OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation
PR Newswire Europe - Wed Jul 01, 9:30AM CDT
HONG KONG and FT LAUDERDALE, Florida, July 1, 2015 /PRNewswire/ --
Disposable Syringes Market (Safety and Conventional Syringes): Global Industry Analysis 2014 - 2022
M2 - Wed Jul 01, 9:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jlbkkq/disposable) has announced the addition of the "Disposable Syringes Market (safety and conventional syringes): Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022" report to their offering. The global disposable syringes market was valued at USD 4,935.7 million in 2013 and is projected to reach USD 7,552.5 million by 2022, expanding at a CAGR of 4.9% during the forecast period from 2014 to 2022. Growth in the injectable drugs market along with increasing needlestick injuries has boosted demand for safe disposable syringes across the world. Disposable syringes have been identified as one of the fastest growing segments of the syringe market, accounting for approximately 70% to 80% of the global market in 2013. Globally, disposable syringes are becoming more popular than re-usable syringes, primarily due to cost, accuracy, sterility, and ease of handling. Increasing cases of needlestick injuries, strict regulatory guidelines, and overall growth in the injectable drugs market have been identified as the major factors driving the growth of the global disposable syringes market. The disposable syringes market has been segmented into two major types: safety syringes and conventional syringes. Syringes equipped with safety mechanisms are known as safety syringes. Safety syringes have been further categorized into automatic retractable safety syringes, manual retractable safety syringes, and non-retractable safety syringes. Conventional syringes are not equipped with any kind of safety mechanisms. Conventional syringes have been classified into syringes without needles and syringes attached with needles. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Disposable Syringes Market Overview Chapter 4 Global Disposable Syringes Market Revenue (USD Million) and Volume (Million Units), by Type, 2012 - 2022 Chapter 5 Global Disposable Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2012 - 2022 Chapter 6 Recommendations Chapter 7 Company Profiles - B. Braun Melsungen AG - Becton, Dickinson & Company - CODAN Medizinische Ger?te GmbH & Co KG - Covidien plc (Medtronic plc) - Gerresheimer AG - Retractable Technologies, Inc. - Smiths Medical - Star Syringe Ltd. - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/jlbkkq/disposable
BDX: 144.27 (+2.44), UNIS: 1.94 (+0.06), MDT: 74.37 (+1.28), RVP: 3.86 (+0.02)
Prefilled Syringes Market Report: Base Year is 2014 with Forecasts for 2015 to 2025
M2 - Wed Jul 01, 8:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mg74nr/prefilled) has announced the addition of the "Prefilled Syringes Market (3rd Edition), 2015 - 2025" report to their offering. Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern devices have become preferred devices for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. The rising demand has also driven the manufacturers to introduce improvements in technology related to the material of prefilled syringes and lubrication (to reduce leachables and extractables). These developments will aid an increasing number of biologic drugs to reach the market. Additionally, the companies have developed multi-chamber prefilled syringes for use with lyophilised drugs. In our research, we have looked at how these developments and other factors are shaping the market and discussed the factors creating opportunities for various stakeholders in the market. The Prefilled Syringes Market (3rd Edition)' report provides a comprehensive analysis of the state of prefilled syringes market. Starting with the basic introduction to prefilled syringes, their origin, components and manufacturing material, this report talks about needlestick injuries and looks at the safety laws and legislations across major regional markets for prefilled syringes. A key objective of the report is to enumerate various prefilled syringe systems available in the market, drugs available in these syringes and the corresponding market potential across different geographical regions. We have discussed various historical/likely future trends which have shaped/will shape the US, European, Japanese, Chinese, Indian and rest of the world markets. We have also included a detailed overview of biologics and biosimilars, one of the primary growth drivers of this market. The study focuses on analysing the existing market size and potential future growth of these drug delivery devices across different drug therapeutic classes and regions. The forecast, over the next ten years, has been presented both in terms of volume (number of units) and value (USD billion). It takes into account the likely price variation which will occur as a result of mass adoption and increased competition. Owing to uncertainty surrounding the adoption of prefilled syringes in newer drug classes (which are currently in pipeline); we have also done a multi-variate sensitivity analysis to understand the various market growth scenarios. The market forecasts across different segments and regions have been presented till 2025. 2014 is the base year; actual figures have been sourced and analysed from publicly available information. Unless otherwise specified, all figures are presented in USD. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction To Prefilled Syringes 4. Needlestick Injuries 5. Growth Drivers 6. Products Available in Prefilled Syringes 7. Recent Developments and Applications of Prefilled Syringes 8. Manufacturers of Prefilled Syringe 9. PFS Component Manufacturers 10. Global Pen and Auto-Injector Manufacturers 11. SWOT Analysis 12. Leading Regional Markets for Prefilled Syringe Systems, 2015 - 2025 13. Global Prefilled Syringes Market Forecast, 2015 - 2025 14. Interview Transcripts 15. Conclusion 16. Appendix 1: Tabulated Data 17. Appendix 2: List of Companies and Organisations Companies Mentioned - ARTE CORPORATION - AbbVie/Eisai - Aguettant - Amgen - Aptar Stelmi - Becton Dickinson (BD) - Bespak - DALI Medical DevicesElcam Medical - Daikyo Crystal Zenith - Datwyler - Elcam Medical - EZ-fill Syringes - Future Injection Technologies - Gerresheimer - J.O. Pharma Co., Ltd. - Nipro Corporation - Nuova Ompi - Owen Mumford - Pfizer - Plajex: Plastic PFS - Roselabs Group - SCHOTT - Takeda - Taisei Kako Co., Ltd. - Terumo Corporation - Teva Pharmaceuticals - TopPac - Unilife Corporation - VF-Syringe Glass PFS - Vetter Pharma - WeGo: Glass PFS - West Pharmaceutical Services, Inc. - YangZhong Wealth Metal Co., Ltd. - Youlyy Industrial Co., Ltd. - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/mg74nr/prefilled
WST: 59.92 (+0.16), UNIS: 1.94 (+0.06), AMGN: 154.10 (+2.79)
Peripheral Vascular Stents Pipeline Review, 2015
M2 - Fri Jun 26, 4:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wtlrn6/peripheral) has announced the addition of the "Peripheral Vascular Stents - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key peripheral vascular stents pipeline products. Scope - Extensive coverage of the Peripheral Vascular Stents products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Peripheral Vascular Stents - Pipeline Products under Development by Companies 5 Peripheral Vascular Stents Companies and Product Overview 6 Peripheral Vascular Stents- Recent Developments 7 Appendix Companies Featured: - 3D Biotek, LLC - 480 Biomedical, Inc. - Abbott Vascular Inc. - Andramed GmbH - Biotronik SE & Co. KG - Boston Scientific Corporation - Contego Medical, LLC - Cook Medical Incorporated - Cordis Corporation - CorInnova, Inc. - Cytograft Tissue Engineering, Inc. - Elixir Medical Corporation - HEXACATH - InspireMD, Inc. - Lifetech Scientific (Shenzhen) Co., Ltd. - MicroVention, Inc. - Nipro Corporation - NSVascular, Inc. - Palmaz Scientific, Inc. - Stentys, SA - Stron Medical - Taewoong Medical Co.,Ltd. - Tepha, Inc. - Terumo Corporation - University of Texas Medical Branch at Galveston - Veniti, Inc. - Veryan Medical Limited - VueKlar Cardiovascular Ltd. - W. L. Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/wtlrn6/peripheral
BSX: 17.60 (+0.15), NSPR: 0.25 (+0.01)
Global Interventional Cardiology & Peripheral Vascular Devices Market 2015 - Forecasts to 2019
M2 - Wed Jun 10, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6kzjg4/interventional) has announced the addition of the "Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019" report to their offering. The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4% The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. The angioplasty stents segment accounted for the largest share of the interventional cardiology and peripheral vascular devices market during the forecast period. The large share of this segment is attributed to the rising prevalence of cardiovascular diseases and increasing initiatives by companies for developing new and technologically advanced stents for better clinical outcomes. Major factors contributing to the growth of the interventional cardiology and peripheral vascular devices market include rising aging population, increasing demand of minimally invasive procedures, rising incidence of cardiovascular diseases, and technological advancements. According to the World Health Organization, in 2012, 17.5 million people died due to CVDs; this figure accounted for 31% of the global deaths in 2012. Furthermore, in the same year, 16 million people aged below 70 years died due to non-communicable diseases; of this, 37% deaths were related to CVDs. Emerging markets in Asia have opened an array of opportunities for the growth of the interventional cardiology and peripheral vascular devices market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market. Key players in this market include Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic Inc. (U.S.), Terumo Corporation (Japan), and Volcano Corporation (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Angioplasty Market Size, By Type of Procedure 8 Angioplasty Balloons Market, By Type 9 Angioplasty Stents Market, By Type 10 Catheters Market, By Type 11 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type 12 Inferior Vena Cava (IVC) Filters Market, By Type 13 Plaque Modification Devices Market, By Type 14 Hemodynamic Flow Alteration Devices Market, By Type 15 Accessories Market, By Type 16 Interventional Cardiology and Peripheral Vascular Devices Market, By Region 17 Competitive Landscape 18 Company Profiles - Abbott Laboratories - B. Braun Melsungen AG - Boston Scientific Corporation - C.R. Bard - Cordis Corporation (A Subsidiary of Johnson & Johnson Co.) - Medtronic, Inc. - Spectranetics International BV - St. Jude Medical, Inc. - Terumo Corporation - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/6k...rventional
BSX: 17.60 (+0.15), SPNC: 24.87 (+0.36), JNJ: 99.53 (+1.13), ABT: 49.93 (+0.74), BCR: 174.54 (+3.34), MDT: 74.37 (+1.28), VOLC: 17.99 (+0.01), STJ: 75.33 (+0.79)
Blood Processing Supplies and Equipment Market 2015 - Global Strategic Business Report
M2 - Tue Jun 02, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mk83rc/blood_processing) has announced the addition of the "Blood Processing Supplies and Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Blood Processing Supplies and Equipment in US$ Thousands by the following Product Group/Segments: - Blood Processing Devices (Blood Bank Freezers, Blood Bank Refrigerators, Blood Cell Processors, Blood Grouping Analyzers, & Hematocrit Centrifuges) - Blood Processing Consumables & Supplies (Blood Administration Sets, Blood Collection Needles, Blood Collection Tubes & Micro Collectors, Blood Collection Tube Adapters, Blood Donor Sets, Blood Sample Mailers, Blood Sampling Kits, Blood Lancets, Blood Tube Mixes, Donor Blood (Blood Bank) Mix, Blood Cell Washer Bags, Blood Filters, Blood Grouping Reagents, Coagulation Reagents, Hematology Reagents, Hematology Stains, Control Plasmas, Microscopic Slides, Sedimentation Tubes, Slide Stainers, Specimen Labels, Test Tube Racks, Vials, Cleaning Solutions, & Blood Warming Coils/Pouches). The report profiles 98 companies including many key and niche players such as - Beckman Coulter, Inc. - Becton, Dickinson and Company - Fresenius Kabi AG - Fenwal, Inc. - Haemonetics Corporation - Immucor, Inc. - MacoPharma SA - Stago - Terumo Corporation - Terumo BCT, Inc. Key Topics Covered: 1. INDUSTRY OVERVIEW 2. COMPETITIVE LANDSCAPE 3. MARKET DYNAMICS 4. BLOOD COMPONENTS & DERIVATIVES 5. BLOOD BANKING 6. AUTOLOGOUS BLOOD TRANSFUSIONS VIS-A-VIS ALLOGENIC BLOOD TRANSFUSIONS 7. AUTOLOGOUS TRANSFUSIONS: MINIMIZING RISK OF BLOOD-BORNE DISEASES 8. BLOOD PROCESSING SUPPLIES AND EQUIPMENT: AN OVERVIEW 9. BLOOD TESTING DEVELOPMENTS - A HISTORIC REVIEW 10. PRODUCT INNOVATIONS/INTRODUCTIONS 11. RECENT INDUSTRY ACTIVITY 12. FOCUS ON SELECT PLAYERS 13. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 98 (including Divisions/Subsidiaries 110) - The United States (52) - Canada (3) - Japan (9) - Europe (31) - - France (2) - - Germany (7) - - The United Kingdom (6) - - Italy (5) - - Spain (2) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (13) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/mk...processing
HAE: 39.22 (+0.51)
MicroVention to Locate Its New 205,000 Square-Foot Worldwide Headquarters At Summit Office Campus in Aliso Viejo
PR Newswire - Mon Jun 01, 9:00AM CDT
MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation and a global neurovascular company, announced today that it will build its new 205,000 square-foot worldwide headquarters at the Summit Office Campus in Aliso Viejo, CA, the city where the Company was originally founded.
Investing in Global Medical Device Sector: Risk Analysis and Management 2014-2020
M2 - Fri May 22, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tlb9zv/investing_in) has announced the addition of the "Investing in Global Medical Device Sector: Risk Analysis and Management 2014-2020" report to their offering. The global medical devices (MD) market represents a steady growing industrial sector as well as an attractive investment opportunity for profitable rewards. However, the potential for greater investment return may be constrained by a number of barriers and risks in global medical device market - most notably, maturing industry growth stage, challenging and changing regulatory laws and procedures, and declining profit margins. Hence, in-depth information and enhanced strategic intelligence are needed to minimize the potential risks associated with new entrants into the global medical device industry. This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (arising from the surrounding environments) in global medical devices industry and market. The major internal risks recognized in this industry include industry growth stage, industry competition pressure, market entry barriers, industry volatility, and technology challenge. The major external risks include factors like profit decline, regulation force, effect of foreign direct investment, and other risks (namely shortage of upstream supply, competition from substitutes, and purchase potential decrease). The risk evaluation and threat rating concentrate on worldwide medical device market under the industry conditions and environments in 2014. Forecasts and projections have been performed for the trend of industry risk over the next six years (2014-2020). All the identified risk factors are measured quantitatively according to our novel numeric system, i.e. each risk is evaluated with our Risk Index Number (RIN) and Risk Intensity Level (RIL). These in-depth appraisals and analysis about risk considerations & controls provide a comprehensive understanding of the current risk factors and likelihood of risk development trends. Moreover, this report also provides wise risk management strategies and concludes Critical Success Factors (CSFs) to help identify fresh growth point and overcome the threats and obstacles of doing manufacture/business in global medical device industry. Key Topics Covered: 1. Introduction 2. Internal Risk 3. External Risk 4. Summary and Forcast 5. Critical Success Factors (CSFS) Companies Mentioned - 3M Co. - Abbott Laboratories - Allergan Inc. - Baxter International Inc. - Becton, Dickinson and Co. - Boston Scientific Corp. - Cardinal Health Inc. - Covidien plc - Essilor International SA - Fresenius Medical Care AG & Co. KGAA - GE Healthcare - Johnson & Johnson - Koninklijke Philips NV - Medtronic Inc. - Novartis AG - Siemens AG - St. Jude Medical Inc. - Stryker Corp. - Terumo Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/tl...vesting_in
ZMH: 113.56 (+0.29), MMM: 154.95 (+1.20), ABT: 49.93 (+0.74), MDT: 74.37 (+1.28), CAH: 85.48 (+1.32), AGN: 312.13 (+8.03), BSX: 17.60 (+0.15), JNJ: 99.53 (+1.13), BAX: 37.61 (+0.59), STJ: 75.33 (+0.79), SYK: 96.37 (+0.71), NVS: 103.22 (+3.20)
Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecasts for the $289 Billion Market
M2 - Fri May 22, 5:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xgr8bv/global_medical) has announced the addition of the "Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecast" report to their offering. The global medical devices (MD) market will see a steady growth over the coming years with the sales revenue and international trade value reaching $543.9 bn and $289.2 bn respectively by 2020 driven by aging population, increasing healthcare expenditure and technology advancement. Global Medical Devices Market 2012-2020 examines the worldwide market of medical devices through a comprehensive review of information sources. This report provides historical performance, in-depth analysis and trend forecast of market size and share, sales revenue, international trade, R&D investment, geographic distributions and product categories by device area in the global medical device market and industry. Historical statistics cover the past three years and forecast data characterize the 2014-2020 period. Market analyses and discussions of commercial drivers, restraints and challenges, emerging market opportunities, competitive environment and technological developments are also reviewed in the report. Geographic sub-markets include continents such as North America, Europe, Asia Pacific region, Latin America and the rest of world, with 12 country-based markets analyzed in detail for market overview, industry landscape, healthcare system and/or regulation issues. Per capita MD expenditure/availability in major economic markets (on country basis) is compared and analyzed. Medical devices are segmented by device area such as Diagnostic Imaging Devices, In Vitro Diagnostics, Cardiology, Orthopedics, Ophthalmics, General and Plastic Surgery, Endoscopy, Dental, Diabetic Care, Wound Management, Nephrology, General Hospital and Healthcare, Ear, Nose and Throat, Neurology and others. The market data and forecast trends are provided for each sub-market in the time range of 2012-2020, highlighted by 62 tables and figures totally. The top 40 medical device manufacturers in 2014 are listed and 20 of them are profiled and studied. Key Topics Covered: 1 Introduction 2 Market Analysis: Drivers, Restraints, Challenge and Opportunity 3 Geographic Distribution of Global Medical Device Market 4 Market Trends of Global Medical Devices by Device Area 5 International Trade of Medical Devices 6 Major Medical Device Manufacturers Companies Mentioned - 3M Co. - Abbott Laboratories - Allergan Inc. - Baxter International Inc. - Becton, Dickinson and Co. - Boston Scientific Corp. - Cardinal Health Inc. - Covidien plc - Essilor International SA - Fresenius Medical Care AG & Co. KGAA - GE Healthcare - Johnson & Johnson - Koninklijke Philips NV - Medtronic Inc. - Novartis AG - Siemens AG - St. Jude Medical Inc. - Stryker Corp. - Terumo Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/xg...al_medical
ZMH: 113.56 (+0.29), MMM: 154.95 (+1.20), ABT: 49.93 (+0.74), MDT: 74.37 (+1.28), CAH: 85.48 (+1.32), AGN: 312.13 (+8.03), BSX: 17.60 (+0.15), JNJ: 99.53 (+1.13), BAX: 37.61 (+0.59), STJ: 75.33 (+0.79), SYK: 96.37 (+0.71), NVS: 103.22 (+3.20)
Olympus to Distribute Terumo GLIDEWIRE®, Urologic Hydrophilic Coated Guidewire for U.S. Urology Market
PR Newswire - Fri May 15, 2:31PM CDT
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE® Urologic Hydrophilic Coated Guidewire, a device cleared by the FDA for urological use. Beginning immediately, the Olympus Urology and Stone Management sales force will distribute the device to U.S. customers.
Cannulas Market by Product, Material & End Users - Global Forecast to 2020
M2 - Wed May 06, 9:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/84mqf9/cannulas_market) has announced the addition of the "Cannulas Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, Cardioplegia, Suction, Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & End Users (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2020" report to their offering. The global cannulas market is expected to grow at a CAGR of 5.6% from 2015 to 2020 to reach $135.5 million by 2020 from $97.6 million in 2014.The market is expected to grow in the forecast period owing to increased investment in R&D, growing demand of minimally invasive surgery (MIS) procedures, large pool of patients, and increasing number of surgeries. However uncertain regulatory framework is hindering the growth of cannula market. On the basis of products, the market is divided into the global cannulas market is segmented into cardiac cannulas, vascular cannulas, nasal cannulas, arthroscopy cannulas, dermatology cannulas and others (floating spinal cannulas, vitreoretinal cannulas, hysterosalpingography cannulas). On the basis of end users, the market is divided into hospitals, ambulatory surgical centers, and others (blood banks and home healthcare facilities). Hospitals segment accounted the largest share of the cannula market as compared to ambulatory surgical centers, and others. On the basis of material, the market is divided into plastic, silicone, and metal. Silicone is expected to be the fastest-growing segment, owing to the increasing usage of silicone-based cannulas in oxygen therapies to provide continuous oxygen supply to the elderly population and patients suffering from respiratory disorders. Geographically, the cannulas market is dominated by North America, followed by Europe. However, the Asia-Pacific region is expected to be the fastest growing region in cannula market during the forecast period. Increasing awareness about MIS techniques in countries such as China, India, and Japan, increasing purchasing power of the middle class population are augmenting the growth of this market in Asia-Pacific region. The key players in cannulas market include Medtronic plc (U.S.), Edward Lifesciences Corp. (U.S.), Terumo Corporation (Japan), Sorin Group (Italy), and Maquet Holding B.V. & Co. KG (Germany). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Cannulas Market, By Application 8 Cannula Market, By Product 9 Global Cannulas Market, By Material 10 Global Cannulas Market, By End User 11 Cannulas Market, By Region 12 Competitive Landscape 13 Company Profiles - Boston Scientific Corporation - Conmed Corporation - Edward Lifescience Corporation - Maquet Holding B.V. & Co. KG. - Medtronic PLC. - Smith & Nephew PLC. - Smiths Medical - Sorin Group - Teleflex Incorporated - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/84...las_market
BSX: 17.60 (+0.15), SNN: 34.89 (+0.83), MDT: 74.37 (+1.28), TFX: 135.95 (+1.47)
Medical Oxygen Systems - 2015 Global Strategic Business Report
M2 - Fri Apr 17, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3p22jk/medical_oxygen) has announced the addition of the "Medical Oxygen Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Medical Oxygen Systems in US$ Thousands by the following Segments: Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 66 companies including many key and niche players such as: - Chart Industries, Inc. (US) - AirSep Corporation (US) - Chart SeQual Technologies, Inc. (US) - DeVilbiss Healthcare (US) - Inogen (US) - Inovo, Inc. (US) - Invacare Corporation (US) - Medical Gas Solutions (UK) - Philips Healthcare (US) - Terumo Corporation (Japan) - Weinmann Ger?te f?r Medizin GmbH Co. KG (Germany) Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET GROWTH DRIVERS, TRENDS AND ISSUES 3. HOME OXYGEN THERAPY MARKET - A CLOSER LOOK 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/INNOVATIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 66 (including Divisions/Subsidiaries - 82) The United States (46) Canada (3) Japan (4) Europe (22) - France (3) - Germany (7) - The United Kingdom (
- Rest of Europe (4) Asia-Pacific (Excluding Japan) (6) Africa (1) For more information visit http://www.researchandmarkets.com/research/3p...cal_oxygen IVC: 20.62 (+0.25), GTLS: 33.57 (-1.41)
Body Temperature Monitoring Devices - Global Strategic Business Report 2015-2020: Its Time for Smart, No-Fuss Thermometers
M2 - Wed Apr 01, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dcjdnj/body_temperature) has announced the addition of the "Body Temperature Monitoring Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Body Temperature Monitoring Devices in US$ Thousands by the following Product Segments: - Digital Thermometers - Infrared Thermometers - Electronic Temperature Monitors - Temperature Strips The report profiles 65 companies including many key and niche players such as: - 3M Company (US) - A&D Medical/LifeSource (US) - Actherm, Inc. (Taiwan) - American Diagnostic Corporation (US) - Briggs Healthcare (US) - Exergen Corporation (US) - Geratherm Medical AG (Germany) - Hicks Thermometers (India) Limited (India) - Kaz USA, Inc. (US) - LCR Hallcrest LLC (US) - Medtronic PLC (US) - Microlife Corporation (Taiwan) - Omron Healthcare, Inc. (Japan) - Mediaid, Inc. (US) - RG Medical Diagnostics (US) - Sanomedics International Holdings, Inc. (US) - Terumo Corporation (Japan) - Welch Allyn, Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS & ISSUES 3. AN INTRODUCTION TO THERMOMETERS 4. PRODUCT OVERVIEW 5. PRODUCT INTRODUCTIONS/INNOVATIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 65 (including Divisions/Subsidiaries (73) - The United States (27) - Canada (1) - Japan (5) - Europe (21) - Germany (5) - The United Kingdom (
- Italy (3) - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (17) - Latin America (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/dc...emperature MMM: 154.95 (+1.20), MDT: 74.37 (+1.28)
MediPoint: Coronary Stents - South America Analysis and Market Forecasts to 2020
M2 - Wed Mar 25, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lz276h/medipoint) has announced the addition of the "MediPoint: Coronary Stents - SA Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Minimally-invasive techniques such as stenting have been widely adopted in Brazil. The coronary stents market will be driven by the rising prevalence of CAD, the growing aging population, and the potential cost savings associated with DES technologies. Scope - An overview of Coronary Stents, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the SA Coronary Stents market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Coronary Stents. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Coronary Stents sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Boston Scientific Corporation - Medtronic - Alvimedica - Amaranth Medical - amg International - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Cardionovum - C.R. Bard - Elixir Medical Corporation - eucatech AG - Hexacath - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MicroPort Scientific Corporation - Minvasys - MIV Therapeutics - Opto Circuits - OrbusNeich Medical - Relisys Medical Devices - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/lz276h/medipoint
BSX: 17.60 (+0.15), MDT: 74.37 (+1.28)
Leading 100 Global Medical Devices Companies 2015
M2 - Mon Mar 23, 10:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nnxw77/global_medical) has announced the addition of the "Global Medical Devices 100 - An Industry Report" report to their offering. The global medical devices industry will witness significant opportunities for growth in the coming decade. It is predicted that the global medical devices market will reach $398.0bn in 2017 This newly launched report covers various aspects of the global medical devices sector including news, as well as financial/non-financial information and stock market analysis of leading 100 global medical devices companies. There has been an increase in demand for the refurbished medical devices market globally, along with the new equipments market. Until a decade ago, refurbished medical devices were exported to developing countries, and the suppliers involved were not professionally trained, which restrained the growth of this market. However, economic crises and cost containment issues related to healthcare budgets in developed countries like the U.S. and the recent economic recession of Europe has triggered the growth of this market in these countries. Additionally, there has been a surge of trained professionals in this segment. Report Highlights: - Leading 100 medical devices companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical devices companies - International presence of global medical devices companies - R&D activities by global medical devices companies Key Topics Covered: 1: Rankings of Medical Devices Companies Globally 1.1: Leading 100 Medical Devices Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Devices Companies Globally 1.3: Most Profitable 25 Medical Devices Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Devices Companies Globally 3: Key News of Medical Devices Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Devices Companies Globally 5: International Presence of Global Medical Devices Companies 6: Research and Development Activities by Global Medical Devices Companies 7: Mergers and Acquisitions among Global Medical Devices Companies Companies Mentioned (Partial List) - Amplifon SpA (Italy) - Bastide le Confort Medical (France) - Digital Optics Co Ltd (South Korea) - Edan Instruments Incorporated (China) - Fujifilm Holdings Corporation (Japan) - Guangzhou Improve Medical Instruments Company Limited (China) - Hitachi High Technologies Corp (Japan) - JVM Co Ltd (South Korea) - Mindray Medical International Limited - adr - ADR (China) - Nan Liu Enterprise Co. Ltd. (Taiwan) - Owens & Minor, Incorporated (United States) - Patterson Companies, Inc. (United States) - Pw Medtech Group Ltd (China) - Suzuken Co (Japan) - Sysmex Corporation (Japan) - Techcomp (Holdings) Ltd. (Singapore) - Teleflex Incorporated (United States) - Terumo Corporation (Japan) - Waters Corporation (United States) - Yamashita Medical Instruments Company Limited (Japan) For more information visit http://www.researchandmarkets.com/research/nn...al_medical
TFX: 135.95 (+1.47), MR: 26.11 (+0.38), WAT: 128.53 (+3.12), OMI: 33.76 (+0.58)
South Africa Cardiovascular Devices Market Opportunity and Growth Trend Forecasts to 2020
M2 - Thu Mar 19, 6:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2nnrg/south_africa) has announced the addition of the "South Africa Cardiovascular Devices Market Opportunity and Growth Trend Forecast Till 2020" report to their offering. The Market Intelligence report provides critical market data for South Africa cardiovascular devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as cardiac assist devices, cardiac catheters and guidewires, cardiac rhythm management, cardiovascular heart valve and repair, cardiovascular monitoring systems, cardiovascular surgery, interventional cardiovascular devices, and peripheral vascular devices. Key Topics Covered: 1 Tables & Charts 2 Introduction 3 Scope of the Report 4 South Africa Market for Cardiovascular Devices (2007-2020) 5 South Africa Market for Cardiac Assist Devices (2007-2020) 6 South Africa Market for Cardiac Catheters and Guidewires (2007-2020) 7 South Africa Market for Cardiac Rhythm Management (2007-2020) 8 South Africa Market for Cardiovascular Heart Valve and Repair (2007-2020) 9 South Africa Market for Cardiovascular Monitoring Systems (2007-2020) 10 South Africa Market for Cardiovascular Surgery (2007-2020) 11 South Africa Market for Interventional Cardiovascular Devices (2007-2020) 12 South Africa Market for Peripheral Vascular Devices (2007-2020) 13 Recent Events and Developments 14 Appendix Companies Mentioned - Abbott Laboratories - AtriCure, Inc. - Biosense Webster, Inc. - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - C.R. Bard, Inc. - Cardiac Science Corporation - Cordis Corporation - Datascope Corp. - Edwards Lifesciences Corporation - ev3 Inc. - Fukuda Denshi Co., Ltd. - GE Healthcare - MAQUET GmbH & Co. KG - Medtronic, Inc. - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Sorin Group - St. Jude Medical Inc. - Terumo Corporation - Thoratec Corporation - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/v2...uth_africa
ABT: 49.93 (+0.74), BCR: 174.54 (+3.34), MDT: 74.37 (+1.28), EW: 147.16 (+2.09), OSIS: 71.42 (+1.63), ATRC: 24.31 (+0.89), BSX: 17.60 (+0.15), STJ: 75.33 (+0.79), THOR: 45.20 (+0.61)
United States Patient Monitoring and Diagnostic Systems Market Assessment and Forecast To 2020
M2 - Wed Mar 18, 7:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zvr9s7/us_patient) has announced the addition of the "US Patient Monitoring and Diagnostic Systems Market Assessment and Forecast To 2020" report to their offering. The Market Intelligence report provides critical market data for US patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as blood pressure monitors, cardiovascular monitoring systems, blood glucose monitoring devices, hearing diagnostics, micro-electromechanical systems multiparameter patient monitors, remote monitoring systems, sleep apnea diagnostic systems and wireless hospital ambulatory monitors. Patient Monitoring and Diagnostics Market Segmentation - Blood Pressure Monitors - Mercury BP Monitors - Aneroid BP Monitors - Automatic BP Monitors - Cardiovascular Monitoring Systems - ECG Monitoring Equipment - ECG Stress Testing Systems - Holter Monitoring Systems - Event Monitoring Systems - Blood Glucose Monitoring Devices - Blood Glucose Meters - Blood Glucose Test Strips - Continuous Glucose Monitoring Systems - Hearing Diagnostics - Audiometer - Otoscope - Micro-Electromechanical Systems - Multiparameter Patient Monitors - Critical Care Monitors - Perioperative Care Monitors - Remote Monitoring Systems - Sleep Apnea Diagnostic Systems - Fixed Polysomnography Systems - Portable Polysomnography Systems - Wireless Hospital Ambulatory Monitors Key Topics Covered: 1 Tables & Charts 2 Introduction 3 Scope of the Report 4 US Market for Patient Monitoring and Diagnostics (2007-2020) 5 US Market for Blood Pressure Monitors (2007-2020) 6 US Market for Cardiovascular Monitoring Systems (2007-2020) 7 US Market for Blood Glucose Monitoring Devices (2007-2020) 8 US Market for Hearing Diagnostics (2007-2020) 9 US Market for Micro-Electromechanical Systems(2007-2020) 10 US Market for Multiparameter Patient Monitors (2007-2020) 11 US Market for Remote Monitoring Systems (2007-2020) 12 US Market for Sleep Apnea Diagnostic Systems (2007-2020) 13 US Market for Wireless Hospital Ambulatory Monitors (2007-2020) 14 Recent Events and Developments 15 Appendix Companies Mentioned - A&D Medical - Abbott Laboratories - Astro-Med, Inc. - Bayer HealthCare AG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial Co., Ltd. - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Corporation - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/zvr9s7/us_patient
ABT: 49.93 (+0.74), MDT: 74.37 (+1.28), CAH: 85.48 (+1.32), COV: 106.71 (-1.36), EW: 147.16 (+2.09), OSIS: 71.42 (+1.63), MR: 26.11 (+0.38), BSX: 17.60 (+0.15), CMD: 95.40 (unch), BABY: 42.30 (+1.11), ALOT: 14.23 (+0.03), STJ: 75.33 (+0.79)
